Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FANSIDAR
- Controlled Human Malaria Infection Transmission Model - Phase A
- The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract
- Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)
- Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2
- Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
- Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi
- Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1
- Phase 2 Efficacy Study of Primaquine and Methylene Blue
- Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)
- Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren
- Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya
- Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria
- Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa
- A Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon Islands
- Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (FansidarĀ®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon
- Intermittent Preventive Treatment (IPTc) and Home Based Management of Malaria (HMM)in The Gambia
- Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)
- Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy
- Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component
- Drug Interaction Between CoartemĀ® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
- Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
- Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Children
- Mass-Drug Administration to Reduce Malaria Transmission
- Treatment of Uncomplicated Malaria in Benin
- IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda
- IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
- IPTi in Mozambican Infants for Malaria Prevention
- Reducing the Effects of Malaria in Children by Administering Repeated Preventive Doses
- Kilimanjaro IPTi Drug Options Trial
- Anti-Malarial Drug Resistance in Cameroon
- Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
- Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
Clinical trials list
click for details